跳转至内容
Merck
CN
  • Blood pool activity on F-18 FDG PET/CT as a possible imaging biomarker of metabolic syndrome.

Blood pool activity on F-18 FDG PET/CT as a possible imaging biomarker of metabolic syndrome.

Scientific reports (2020-10-17)
Ji-In Bang, Chang Mo Moon, Hye Ok Kim, Seo Young Kang, Hai-Jeon Yoon, Bom Sahn Kim
摘要

Association of blood pool (BP) and adipose tissue activity from F-18 fluorodeoxyglucose positron-emission tomography/computed tomography (FDG PET/CT) with the parameters of metabolic syndrome (MetS) and different MetS/obesity types were investigated. 245 subjects underwent FDG PET/CT scan for health check-ups were investigated retrospectively. Associations of BP (BP SUV: SUVmax, SUVmean), visceral (VAT SUV), and subcutaneous adipose tissue (SAT SUV) activity with parameters of MetS, body mass index (BMI), and lipid profiles were analyzed. MetS/obesity types were subdivided into metabolically healthy obese (MHO) and metabolically unhealthy obese (MUO). BP SUV was higher in subjects with MetS (t-test, P < 0.005), and was associated with MetS from multivariable binary logistic regression (OR 5.232 P = 0.010). BP SUV was statistically higher in MUO than in MHO (P < 0.05) along with blood pressure, triglycerides, and HDL-cholesterol. Multivariable binary logistic regression analysis showed MUO had higher blood pressure and BP SUV, while lower HDL-cholesterol relative to MHO after adjusting for triglycerides.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
荧光素二(β-D-吡喃半乳糖苷)